Last quarter (Q2 2022), ValiRx plc's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, ValiRx plc's net income was $―. See ValiRx plc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ ―	$ 9.60K	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ 1.44K	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ 8.16K	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ ―	$ 2.31M	$ ―	$ 1.68M	$ 1.53M	$ 2.70M
Operating Income	$ ―	$ -2.30M	$ ―	$ -1.68M	$ -1.53M	$ -2.70M
Net Non Operating Interest Income Expense	$ ―	$ -4.42K	$ ―	$ 2.77K	$ 14.88K	$ 21.18K
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ -2.30M	$ ―	$ -1.68M	$ -1.54M	$ -2.72M
Tax Provision	$ ―	$ -175.17K	$ ―	$ -133.41K	$ -75.18K	$ -293.74K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -2.04M	$ ―	$ -1.52M	$ -1.44M	$ -2.39M
Basic EPS	$ ―	$ -0.02	$ ―	$ -0.02	$ -0.04	$ -41.25
Diluted EPS	$ ―	$ -0.02	$ ―	$ -0.02	$ -0.04	$ -41.25
Basic Average Shares	$ ―	$ 101.57M	$ ―	$ 65.00M	$ 37.90M	$ 57.77K
Diluted Average Shares	$ ―	$ 101.57M	$ ―	$ 65.00M	$ 37.90M	$ 57.77K
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ 2.31M	$ 2.59M	$ -1.68M	$ -1.53M	$ -2.70M
Net Income From Continuing And Discontinued Operation	$ ―	$ -2.04M	$ ―	$ -1.52M	$ -1.44M	$ -2.39M
Normalized Income	$ ―	$ -2.48M	$ -2.11M	$ -1.81M	$ -1.62M	$ -3.01M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ ―	$ -2.30M	$ -2.59M	$ -1.68M	$ -1.54M	$ -2.72M
EBITDA	$ ―	$ -2.04M	$ -2.59M	$ -1.68M	$ -1.54M	$ -2.72M

Currency in USD

ValiRx plc Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing